Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 19, 2011
Expert second-opinion pathology review of lymphoma in the era of the World Health Organization classificationM J Matasar, W Shi, J Silberstien, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 13, 2001
Chemokine gene expression and clonal analysis of B cells in tissues involved by lymphoid interstitial pneumonitis from HIV-infected pediatric patientsJ Teruya-Feldstein, D W Kingma, A Weiss, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2009
Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphomaR Schaffel, C V Hedvat, J Teruya-Feldstein, et al.Leukemia|December 2, 2005
Results of a phase I/II trial adding carmustine (300 mg/m2) to melphalan (200 mg/m2) in multiple myeloma patients undergoing autologous stem cell transplantationR L Comenzo, H Hassoun, T Kewalramani, et al.Blood|April 15, 1997
Mig, the monokine induced by interferon-gamma, promotes tumor necrosis in vivoC Sgadari, J M Farber, A L Angiolillo, et al.Cytogenetic and Genome Research|November 15, 2007
Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative subsets and histologic progressionG Nanjangud, P H Rao, J Teruya-Feldstein, et al.The Journal of Experimental Medicine|December 22, 1998
Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growthS E Pike, L Yao, K D Jones, et al.Blood|July 11, 2000
Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndromeL Quintanilla-Martinez, S Kumar, F Fend, et al.The Journal of Pathology|July 15, 2006
Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancerL Montanaro, M Brigotti, J Clohessy, et al.Blood|April 15, 1996
p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomasL Hernandez, T Fest, M Cazorla, et al.Pageof 4